Part:BBa_K1462520:Design
GAL1+YFP+SH3-lig+ADH1+GAL1+GFP+PDZ-lig+ADH1+GAL1+BFP+GBD-lig+ADH1
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 150
Illegal AgeI site found at 1755
Illegal AgeI site found at 3300 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 2804
Design Notes
This device is composed of three parts "GAL1 + BFP + GBD ligand + ADH1"[BBa_K1462490],"GAL1 + GFP + BFP ligand + ADH1"[BBa_K1462500] and GAL1 + YFP + SH3 ligand + ADH1[BBa_K1462510]. We planned to transmit this device to yeast with the different scale group of GBD,PDZ and SH3 scaffold protein.
Source
This device is composed of three parts "GAL1 + BFP + GBD ligand + ADH1"[BBa_K1462490],"GAL1 + GFP + BFP ligand + ADH1"[BBa_K1462500] and GAL1 + YFP + SH3 ligand + ADH1[BBa_K1462510].
References
[1] John E Dueber, Gabriel C Wu, G Reza Malmirchegini, et al.Synthetic protein scaffolds provide modular control
over metabolic flux.Nat Biotechnol. 2009 Aug;27(8):753-9.
[2] Schultz, J. et al. Specific interactions between the syntrophin PDZ domain and
voltage-gated sodium channels. Nat Struct Biol 5, 19-24 (1998).
[3] Kim, A.S., Kakalis, L.T., Abdul-Manan, N., Liu, G.A. & Rosen, M.K.
Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome
protein. Nature 404, 151-158 (2000).
[4] Wu, X. et al. Structural basis for the specific interaction of lysine-containing
proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 3, 215-226 (1995).
[5] Harris, B.Z., Hillier, B.J. & Lim, W.A. Energetic determinants of internal motif
recognition by PDZ domains. Biochemistry 40, 5921-5930 (2001).
[6] Dueber, J.E., Yeh, B.J., Chak, K. & Lim, W.A. Reprogramming control of an
allosteric signaling switch through modular recombination. Science 301, 1904-1908 (2003).
[7] Nguyen, J.T., Turck, C.W., Cohen, F.E., Zuckermann, R.N. & Lim, W.A.
Exploiting the basis of proline recognition by SH3 and WW domains: design of
N-substituted inhibitors. Science 282, 2088-2092 (1998).